Dairy cattle experience significant pain from lameness, mastitis, calving complications, and routine husbandry procedures — yet pain management in dairy farming remains inconsistent and inadequate. The gap between available science and on-farm practice represents one of the most significant addressable welfare failures in agriculture.
Pain Prevalence: Lameness: 25-36% of UK dairy cows | Mastitis: 40-60% cows affected per lactation | Sole ulcers: 10-15% prevalence | Pain management provided in: ~30% of lameness cases | Dehorning with analgesia: varies from 5% (US) to 70%+ (Switzerland)
Lameness Pain
Lameness is the most significant chronic pain condition in dairy cattle. Research on pain in lame cattle:
Sole ulcers and white line disease cause pain detectable by: gait scoring, pressure plate analysis, accelerometry, and behavioral indicators (less time standing, reduced feeding)
Lame cows show reduced time at the feed barrier — evidence of pain-related behavioral change affecting nutritional welfare
NSAIDs (meloxicam, ketoprofen) reduce pain indicators and improve production outcomes — demonstrating both welfare and economic case for treatment
Despite evidence, pain assessment and treatment is not systematically applied on most farms — relying on clinical presentation rather than routine welfare monitoring
Mastitis Pain
Undertreated Condition: Clinical mastitis causes significant pain — udder inflammation, fever, and systemic endotoxemia in severe cases. Analgesics are prescribed for only 30-40% of mastitis cases in most countries despite evidence of pain and welfare benefit from treatment. Barriers: cost; time (administering injections to each case); prescribing requirements; and belief that cows recover without pain management.
Dehorning and Disbudding Pain
Horn removal is performed on most dairy calves to prevent adult injury. Disbudding (cautery iron on young calves) and dehorning (adult horn removal) both cause significant pain. Scientific consensus: local anesthesia alone is insufficient (wears off post-procedure); NSAID pre-treatment reduces both acute and post-procedure pain. Several countries mandate sedation and/or analgesia: Switzerland (sedation + local analgesia + NSAID), New Zealand (local anesthesia), some US states beginning to require analgesia.
The business case for pain management is increasingly supported: meloxicam treatment of lame cows increases milk production and reduces culling risk; mastitis analgesic treatment improves recovery speed; dehorning with analgesia reduces growth setback. The economic and welfare cases are aligned — the primary barriers are habit, knowledge gaps, and prescribing access.